Longpre Lara - Insider Non-Derivative Transactions at Mirum Pharmaceuticals, Inc. (MIRM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 2, 2024, Longpre Lara's relationship to Mirum Pharmaceuticals, Inc. (MIRM) is Officer (CHIEF DEVELOPMENT OFFICER), and currently has 104,407 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MIRM insiders.
Data Source: SEC.
Longpre Lara - Insider Non-Derivative Transactions of MIRM Common Stock
Longpre Lara - Insider Non-Derivative Transactions at MIRM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 3, 2024 | Sell -- (Common Stock) | 847 | 26.19 | 104407 |
| Jan 9, 2024 | Sell -- (Common Stock) | 1019 | 28.04 | 105254 |
| Nov 11, 2023 | Acquisition -- (Common Stock) | 434 | 22.29 | 106273 |
| Jul 4, 2023 | Sell -- (Common Stock) | 1004 | 25.65 | 105839 |
| May 11, 2023 | Acquisition -- (Common Stock) | 684 | 16.92 | 106843 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 9625 | 0 | 106159 |
| Jan 10, 2023 | Sell -- (Common Stock) | 1003 | 20.62 | 104369 |
| Sep 11, 2019 | P -- (Common Stock) | 965 | 10.64 | 105372 |